Want to join the conversation?
$AMGN's US product sales for 2015 rose across the portfolio except for EPOGEN and NEUPOGEN, which fell 9% and 5%, respectively. The US increase was driven primarily by increases in net selling prices. The decrease in Rest of the World product sales for 2015 reflects unfavorable changes in FX rates and declines in net selling prices.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?